PP1 5 mg | Purity Not Available StressMarq Biosciences Src kinase inhibitor More Information Supplier Page × PP1
DMPQ Dihydrochloride 25 mg | Purity Not Available StressMarq Biosciences PDGFRβ kinase inhibitor More Information Supplier Page × DMPQ Dihydrochloride
SGI-1027 5 mg | Purity Not Available StressMarq Biosciences DNA Methyl transferase inhibitor More Information Supplier Page × SGI-1027
(1R,1’R)-1,1′-Bis[bis(4-methoxy-3,5-dimethylphenyl)phosphino]-2,2′-bis[(R)-(dimethylamino)phenylmethyl]ferrocene| ChemScene 100mg | >98% ChemScene More Information Supplier Page × (1R,1’R)-1,1′-Bis[bis(4-methoxy-3,5-dimethylphenyl)phosphino]-2,2′-bis[(R)-(dimethylamino)phenylmethyl]ferrocene| ChemScene
(1R,1’R)-1,1′-Bis[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]-2,2′-bis[(R)-(dimethylamino)phenylmethyl]ferrocene inquiry | Purity Not Available Alfa Chemistry More Information Supplier Page × (1R,1’R)-1,1′-Bis[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]-2,2′-bis[(R)-(dimethylamino)phenylmethyl]ferrocene
(1R,1’R)-1,1′,2,2′,3,3′,4,4′-Octahydro-1,1′-biisoquinoline inquiry | 97% Alfa Chemistry More Information Supplier Page × (1R,1’R)-1,1′,2,2′,3,3′,4,4′-Octahydro-1,1′-biisoquinoline
(1R,1’R)-1,1′,2,2′,3,3′,4,4′-octahydro-1,1′-biisoquinoline| ChemScene 250mg | >98% ChemScene More Information Supplier Page × (1R,1’R)-1,1′,2,2′,3,3′,4,4′-octahydro-1,1′-biisoquinoline| ChemScene
(1r,1’r)-2,2′-(3,11-Dioxo-4,10-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquindline)-dioxalate inquiry | Purity Not Available Alfa Chemistry More Information Supplier Page × (1r,1’r)-2,2′-(3,11-Dioxo-4,10-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquindline)-dioxalate
(1R,1’R)-4,4′-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(3,5,5-trimethylcyclohex-3-enol) 1g | 98% BLD Pharmatech Ltd. More Information Supplier Page × (1R,1’R)-4,4′-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(3,5,5-trimethylcyclohex-3-enol)
(1R,1’R)-4,4′-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(3,5,5-trimethylcyclohex-3-enol) 250mg | 98% BLD Pharmatech Ltd. More Information Supplier Page × (1R,1’R)-4,4′-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(3,5,5-trimethylcyclohex-3-enol)
(1R,1’S,3’R/1R,1’R,3’S)-L-054,264 5 mg | Purity Not Available TargetMol somatostatin sst2 receptor agonist More Information Supplier Page × (1R,1’S,3’R/1R,1’R,3’S)-L-054,264
(1R,1’S,3’R/1R,1’R,3’S)-L-054,264 50 mg | Purity Not Available TargetMol somatostatin sst2 receptor agonist More Information Supplier Page × (1R,1’S,3’R/1R,1’R,3’S)-L-054,264
(1R,1’S,3’R/1R,1’R,3’S)-L-054,264 100 mg | Purity Not Available TargetMol somatostatin sst2 receptor agonist More Information Supplier Page × (1R,1’S,3’R/1R,1’R,3’S)-L-054,264